Representative Matters
代表事项
REFERENZMANDATE
Mergers and Acquisitions
- Pond5 in its acquisition by Shutterstock
- Tara Biosystems in its acquisition by Valo Health
- Celtra in its acquisition by Symphony Technology Group
- Talla in its acquisition by Seva
- StreetLinx in its acquisition by Symphony
- Citus Health in its acquisition by Brightree, a subsidiary of ResMed
- arfa in its acquisition of Yaguara
- Hibercell in its acquisition of Biothera Pharmaceuticals’ Imprime PGG program
- Thrive Global in its acquisition of ZP Group and partnership with Walmart
- Thrive Global in its acquisition of Boundless Mind
- Syntimmune in its acquisition by Alexion Pharmaceuticals
- Aspire Health in its acquisition by Anthem
- Orchard Platform in its acquisition by Kabbage
- Glossier in its acquisition of Dynamo E-Media
- Thar Pharmaceuticals in its acquisition by Grünenthal
- Songza in its acquisition by Google
- M5 Networks in its acquisition by ShorTel
- XGraph in its acquisition by Add This (formerly Clearspring)
- Fidelis Security Systems in its acquisition by General Dynamics
- Nomi Technologies in its acquisition by Brickstream
- Tagman in its acquisition by Ensighten
- EveryScreen Media in its acquisition by Media6Degrees
- Fairhaven Capital in the acquisition of its portfolio company, CrowdTwist, by Oracle
Public Company Transactions
- Codiak BioSciences in its $83 million initial public offering and $66 million follow-on offering
- Foundation Medicine in its (i) $120 million initial public offering, (ii) collaboration and equity transaction with Roche, with total value in excess of $1 billion and (iii) sale of the remaining minority interest to Roche for $2.4 billion
- Ocera Therapeutics in its (i) acquisition by Mallickrodt for up to $117 million in upfront cash and contingent (CVR) consideration, (ii) $28 million PIPE financing, (iii) $25 million public offering and (iv) $25 million “at the market” offering facility
- Allena Pharmaceuticals in its $75 million initial public offering
- Chiasma in its (i) $102 million initial public offering, (ii) $34.5 million follow-on offering, (iii) $55 million follow-on offering, (iv) $70 million follow-on offering and (v) acquisition by Amryt
- The underwriters in (i) the $184 million initial public offering, (ii) a $116 million follow-on offering, (iii) a $230 million follow-on offering, (iv) a $200 million “at the market” offering facility and (v) a $200 million convertible note offering of Intrexon
- Vivo Capital in investments in ASLAN Pharmaceuticals, BioPharmX, Strongbridge Pharma, Kadmon, MEI Pharma, Sierra Oncology and Selecta BioSciences
- Intralinks, Tranzyme and Tengion in their initial public offerings
Company-Side Private Financings
- Glossier in various financings with participation by Lone Pine Capital, Institutional Venture Partners, Thrive Capital, Forerunner Ventures and Index Ventures
- Thrive Global in various financings with participation by Kleiner Perkins, Owl Ventures, JAZZ Venture Partners, IVP, Marc Benioff, Ray Dalio and Kevin Durant
- arfa in its financings by Forerunner, Index, White Star Capital, Thrive, Box Group and others
- Chord Commerce in its financing by Eclipse Ventures and Foundation Capital
- Instant Teams in its financing led by Tiger Global
- Avvir in various financings from investors that included Trust Ventures, Khosla Ventures, LocalGlobe, MetaProp NYC and Stacked Capital
- Biteable in its Series A financing led by Cloud Apps Capital Partners
- Prevu in its financing led by Corigin Ventures
- Celtra in various financings with participation by WPP, Unilever, Grandbanks Capital and Fairhaven Capital
- Digital Power Optimization Partners in its financing led by NYDIG
- Orchard Platform in its financing led by Thrive Capital, Spark Capital and Canaan Partners
- Hubble Contacts in various financings with participation by First Mark Capital, Two River, Wildcat Capital Management, Founders Fund, Greycroft and Colgate
- Aircall in various financings with participation by Draper Esprit, Next World Capital, Balderton Capital and eFounders
- Linkwell Health in various financings with participation by HLM Venture Partners and Spark Capital
- Even Financial in its financing led by Canaan Partners and Lerer Hippeau Ventures
- Pond5 in its financing by Accel Partners and Stripes Group
- Paperless Post in various financings with participation by August Capital, Sherpalo Ventures, RRE Ventures, Mousse Partners and Top Tier
- Megaphone TV in its financing led by Softbank Korea
Investor-Side Private Financings
- Glasswing Ventures in various private investments, including Plannuh, Narrative, Talla, ZyloTech, Inrupt, ChaosSearch, askfora, Verusen, Elios, Narrative I/O, Labviva
- Perceptive Advisors in various investments, including Dynacure, Athira Pharma, Kindbody, Freenome and AavantiBio
- B Capital in various investments, including Lively, Hotspot Therapeutics, OncoMyx and Triumvira Immunologics
- InterWest and Orbimed, as lead investors, in a $32 million investment in Avedro
- Hermed Capital in its investments in Prognos and Spineology
- Macquarie Capital in various investments and strategic collaborations
Professional Activities
Mr. Lang is a frequent lecturer at the Cardozo Tech Law Start Up Clinic, Columbia Business School, Columbia Law School, Cornell Tech, Food-X and eLab NYC on venture financings and other elements of start-up law.